Home - Products - Others - Other Targets - KKI-5 TFA(97145-43-2 free base)

KKI-5 TFA(97145-43-2 free base)

CAS No. ——

KKI-5 TFA(97145-43-2 free base)( —— )

Catalog No. M30078 CAS No. ——

KKI-5 (TFA) is a specific tissue kallikrein inhibitor.Kki-5 (TFA) can reduce breast cancer cell infiltration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    KKI-5 TFA(97145-43-2 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    KKI-5 (TFA) is a specific tissue kallikrein inhibitor.Kki-5 (TFA) can reduce breast cancer cell infiltration.
  • Description
    KKI-5 (TFA) is a specific tissue kallikrein inhibitor.Kki-5 (TFA) can reduce breast cancer cell infiltration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Kallikrein
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    887.9
  • Molecular Formula
    C37H56F3N11O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Deshpande MS, et al. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392. J Med Chem. 1992 Aug 21;35(17):3094-102.
molnova catalog
related products
  • Praeruptorin C

    Praeruptorin C has been widely used as an antioxidant and a calcium antagonist to treat diseases.

  • Acegastrodine

    Acetagastrodin has an antispasmodic effect on vascular smooth muscle.

  • HG106

    HG106, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene.